• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE OMNI S; BLOOD GAS ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE OMNI S; BLOOD GAS ANALYZER Back to Search Results
Catalog Number 03337154001
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/03/2021
Event Type  malfunction  
Manufacturer Narrative
Na.
 
Event Description
The initial reporter complained of discrepant results for 1 patient tested for pco2 on a cobas b221 instrument compared to a cobas b123 instrument.The cobas b123 system is not sold or available for sale in the us.The result from the b221 was 71.3 mmhg.The result from the b123 was 81.1 mmhg.The results were from 2 different samples obtained approximately 20 minutes apart.It is not clear which result was believed to be correct.The pco2 cassette lot number and expiration date were not provided.
 
Manufacturer Narrative
Two different arterial blood samples were measured for the same patient and tested on the b221 instrument and a b123 instrument; both were syringe measurements.The sample container was provided as a gas syringe with lyophilized lithium heparin.For the b221 instrument: no correlation factors were applied.It is unknown when the pco2 electrode was installed and the lot number was not provided.During a review of the results obtained on both the b221 and the b123 instruments: the po2 and pco2 parameters were measured higher on the b123 and ph was measured lower.Both instruments showed an fio2 of 0.85.The fio2 results could indicate non-invasive respiratory support to the patient due to respiratory difficulties.The increased po2 amount measured on the b123 instrument could have occurred due to the respiratory support and the decrease in the ph value caused the normal physiological increase in pco2.Different samples from the same patient may show different results due to the patient's health status changing in the time between the two measurements.If liquid heparin was still in the syringe when the sample for the b221 was obtained, there is a risk of over diluting the sample which could cause low pco2 results.Based on the hct (18.5%) and thb (3.8 g/dl) results from the b221 instrument it was determined the sample had a lower amount of red blood cells and was likely diluted compared to the sample run on the b123 instrument.The lower glucose (140 mg/dl) and higher lactate (1.4 mmol/l) results from the b123 instrument indicate the blood composition changed slightly along with the higher pco2 result indicating respiratory acidosis.For the b221 instrument: the pco2 calibration are stable from (b)(6) 2021 through (b)(6)-2021.The pco2 electrode was replaced on (b)(6)-2021 with electrode lot number 21511465.For the b221 instrument: a system stop alarm was observed on (b)(6)-2021 2 hours prior to the low pco2 result and 2 hours after the low pco2 result.This alarm indicates that the sample sensor recognized an insufficient amount of rinse solution during the rinse procedure.No system stop alarm occurred for the alleged sample that could have influenced the pco2 result.For the b221 instrument: qc data for pco2 showed all values were in range prior to and on (b)(6)-2021.Based on the investigation of the database files, no instrument or electrode related issue occurred that could have caused a discrepant pco2 result.Based on the low hct result of 18.5% and the low thb of 3.8 g/dl on the b 221 instrument the event is consistent with a diluted sample due to a pre-analytical handling issue.It is likely that the sample measured on the b 221 was diluted by the anticoagulant or by another substance.The investigation did not identify a product problem with the b 221 instrument.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE OMNI S
Type of Device
BLOOD GAS ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key12438909
MDR Text Key273123224
Report Number1823260-2021-02637
Device Sequence Number1
Product Code CHL
UDI-Device Identifier04015630018345
UDI-Public04015630018345
Combination Product (y/n)N
PMA/PMN Number
K032311
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 10/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03337154001
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 08/19/2021
Initial Date FDA Received09/08/2021
Supplement Dates Manufacturer Received10/01/2021
Supplement Dates FDA Received10/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-